Orforglipron (CAS 2212020-52-3) is a non-peptidic small molecule compound designed for GLP-1 receptor related research. It is widely used in metabolic and endocrine system studies due to its receptor interaction properties and stable chemical structure.

This compound is applied in scientific research focused on glucose regulation, receptor signaling pathways, and metabolic mechanism exploration.

• Non-peptide small molecule structure
• GLP-1 receptor activity profile
• High chemical stability
• Suitable oral active research model
• Strong receptor interaction potential
• High purity synthetic grade
• Consistent analytical performance
• Advanced metabolic research tool

• Metabolic pathway research
• GLP-1 receptor mechanism studies
• Endocrine system research
• Glucose regulation studies
• Receptor signaling research
• Small molecule screening
• Biochemical laboratory research
• Life science research models

Orforglipron is a non-peptidic small molecule designed to interact with GLP-1 receptor systems in research models. Its structure provides good chemical stability and suitability for long-term laboratory studies in metabolic research environments.

• Non-peptide small molecule structure
• High receptor targeting potential
• Stable chemical profile
• Suitable for metabolic research systems
• High purity laboratory grade
• Reliable analytical consistency

Store in a tightly sealed container at -20°C in a dry, dark environment. Avoid repeated freeze-thaw cycles to maintain stability and performance.

• 1 mg / 5 mg / 10 mg vials
• Powder or lyophilized form
• Custom bulk packaging available

Each batch is tested for identity, purity, and impurity profile using HPLC and LC-MS analytical methods to ensure consistent quality for research applications.